Hypertrophy, Left Ventricular: all 162 studies
Page 1 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)Not yet recruitingNCT07872852Not applicable
- Can Exercise Electrocardiography Discriminate Hypertensive Heart Disease From Obstructive Coronary Artery Disease? A Multimodality Imaging StudyRecruitingNCT07847463
- Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)Not yet recruitingNCT07735130Phase 4
- Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular HypertrophyNot yet recruitingNCT07734285Not applicable
- Study of LX2006 Gene Therapy in Friedreich Ataxia CardiomyopathyRecruitingNCT07721025Phase 2
- AI-based Echocardiography for Detection of Cardiac AmyloidosisNot yet recruitingNCT07529860Not applicable
- Left Ventricular Hypertrophy in CKD PatientsNot yet recruitingNCT07380893
- AI-Enabled Diagnosis and Prognosis of Hypertrophic CardiomyopathyRecruitingNCT07263204
- US Benchmarking Clinical StudyRecruitingNCT07215715
- Evaluation of Left Ventricular Ejection Fraction Using an Accelerated Cardiac Cine-MRI Sequence With Deep Learning-based Image ReconstructionsRecruitingNCT07061821Not applicable
- Predictors of Poor Prognosis in HFpEFRecruitingNCT06844032
- Echocardiographic Analysis by Artificial Intelligence in HypertensionRecruitingNCT06680986
- Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEFRecruitingNCT06655480Phase 2
- Austrian Hypertrophic Cardiomyopathy RegistryRecruitingNCT06368518
- Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular HypertrophyRecruitingNCT06169358
- A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseaseRecruitingNCT06092034Phase 2
- The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)RecruitingNCT06081049Phase 2
- Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.RecruitingNCT05942729
- A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection SoftwareEnrolling by invitationNCT05903313
- Effect of Azilsartan on Atrial Fibrillation in Patients With HypertensionNot yet recruitingNCT05841654Phase 4
- Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy AdultsRecruitingNCT05719337
- Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in HypertensionRecruitingNCT05593055Phase 4
- Assessment and Digital-health Based Intervention on Subclinical Organ Damage and Cardiovascular Risk in ChineseNot yet recruitingNCT05435898
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)RecruitingNCT04752293
- Postnatal Steroids Effects on Cardiac Function in Extremely PretermRecruitingNCT04644094
- Imaging Histone Deacetylase in the HeartRecruitingNCT03549559Not applicable
- Diffusion MRI in Heart FailureRecruitingNCT02973633Early Phase 1
- Response of the Myocardium to Hypertrophic Conditions in the Adult PopulationRecruitingNCT02670031
- The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure PatientsCompletedNCT03300427Phase 4Results posted
- Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.CompletedNCT02970669Phase 4Results posted
- Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot StudyTerminatedNCT01275339Phase 4Results posted
- Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot StudyTerminatedNCT01272388Phase 4Results posted
- Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular HypertrophyTerminatedNCT01188369Phase 4Results posted
- 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant RecipientsCompletedNCT01169701Phase 4Results posted
- The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5TerminatedNCT00616902Phase 3Results posted
- Hypertension in Hemodialysis Patients (Aim 3)TerminatedNCT00582114Phase 3Results posted
- The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4CompletedNCT00497146Phase 3Results posted
- Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular HypertrophyCompletedNCT00446563Phase 3Results posted
- Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)CompletedNCT00348686Phase 4Results posted
- Treatment of Preclinical Hypertrophic Cardiomyopathy With DiltiazemCompletedNCT00319982Phase 2/3Results posted
- Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential HypertensionCompletedNCT00219141Phase 3Results posted
- The CLEVER Study - Coreg And Left Ventricular Mass RegressionCompletedNCT00108082Phase 3Results posted
- Dietary Sodium Intake in Children on Chronic DialysisStatus unknownNCT06165640
- Point-of-care Ultrasound and Treatment Disparities for Left Ventricular HypertrophyCompletedNCT05730309Not applicable
- The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle DiseasesStatus unknownNCT05726695
- Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular HypertrophyCompletedNCT05713916Not applicable
- A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure RiskCompletedNCT05646056
- Sodium Lowering Vascular Effects TrialActive, not recruitingNCT05388032Not applicable
- Stress Reduction in the Prevention of Left Ventricular HypertrophyCompletedNCT05373732Not applicable
- Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis InterventionStatus unknownNCT05241431Phase 2/3
- SGLT2 Inhibition in HemodialysisCompletedNCT05179668Phase 2
- Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University HospitalStatus unknownNCT05002010
- Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.Status unknownNCT04929600Phase 4
- The COlchicine HypERtENsion TrialActive, not recruitingNCT04916522Phase 2
- CMR T1 Mapping for Diagnosis of Cardiac AmyloidosisCompletedNCT04862273
- Longitudinal Follow-up Study in Two Chinese Hypertension CohortsStatus unknownNCT04471389
- Empagliflozin and Cardiac Remodelling in People Without DiabetesCompletedNCT04461041Phase 4
- Transcatheter Aortic Valve Implantation in Western NORwayCompletedNCT04417829
- Demographical and Clinical Profile of Patients With Left Ventricular HypertrophyCompletedNCT04275882
- Protective Monocytes and Macrophages to Limit Decompensation and Heart DamagingStatus unknownNCT04022330Not applicable
- LCZ696 in Advanced LV Hypertrophy and HFpEFCompletedNCT03928158Phase 2
- ReNEW Clinic Cohort StudyCompletedNCT03816462
- Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.CompletedNCT03759002
- Towards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD StudyCompletedNCT03749551
- Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV DiseaseCompletedNCT03666351Phase 4
- FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)CompletedNCT03489993
- Predictors of Left Ventricular Hypertrophy in Hypertensive Patients in Assiut GovernorateCompletedNCT03482934
- Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart DiseaseCompletedNCT03476785Not applicable
- The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic SyndromeStatus unknownNCT03473951
- Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive WomenStatus unknownNCT03432468Not applicable
- Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal TransplantsCompletedNCT03415750Phase 4
- Mechanism of Decompensation Evaluation - Aortic StenosisCompletedNCT03332745
- Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)CompletedNCT03322319Not applicable
- Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II StudyWithdrawnNCT03315832Phase 2/3
- Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS)CompletedNCT03310684
- Remote Ischaemic Conditioning on Blood Pressure Control in Chronic Kidney Disease PatientsStatus unknownNCT03236350Not applicable
- Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECGCompletedNCT03219632
- Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant PatientSuspendedNCT03193073Not applicable
- Reduction of Left Ventricular Hypertrophy After Eplerenone TherapyCompletedNCT03186742Phase 4
- Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis PatientsCompletedNCT03182699Phase 4
- Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVHCompletedNCT03180593Phase 4
- Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe ASActive, not recruitingNCT03094143Not applicable
- Investigation of Dietary Nitrate Effects in Hypertension-induced Target Organ DamageCompletedNCT03088514Phase 2
- Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension.CompletedNCT03068364
- MRI Sequence and Imaging Protocol DevelopmentStatus unknownNCT03040947
- Semmelweis Sport StudyStatus unknownNCT03025737
- Effects of a Reduction in Renal Function on Cardiovascular Structure and FunctionCompletedNCT02973607
- Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?CompletedNCT02956811Phase 4
- Cardiac (CMRI) Assessment of AcromegalyCompletedNCT02948322Not applicable
- Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement TherapyCompletedNCT02908724
- Antihypertensive Treatment in Masked HypertensionCompletedNCT02893358Phase 4
- Predictive Factors of Systolic Dysfunction in Non-complicated Hypertensive PatientsCompletedNCT02841696
- Blood Pressure Follow-up Study in Two Chinese Cohorts(C-BPCS)Status unknownNCT02734472
- In-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up StudyCompletedNCT02684773
- Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly CardiomyopathyCompletedNCT02611336Phase 2
- Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrsCompletedNCT02611258Phase 2
- Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart FailureCompletedNCT02599480Phase 2
- Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot StudyStatus unknownNCT02493465Phase 4
- EMPower: Electronic Media Powering Positive Health Changes in YouthCompletedNCT02444689Not applicable
- Left Atrial Volume Index in Asymptomatic Aortic StenosisCompletedNCT02395107